Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,501.24
(
0.77%
)
US TECH 100
28,391.20
(
-1.39%
)
Dow Jones
50,063.46
(
0.75%
)
Brent Oil
106.51
(
2.24%
)
Bitcoin
80,485.63
(
-0.70%
)
News Focus
News Focus
Post# of 257566
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

exwannabe

Send PM Follow Ignore
Followers 92
Posts 20563
Boards Moderated 0
Alias Born 09/06/2006

exwannabe

Re: DewDiligence post# 83011

Sunday, 08/30/2009 7:49:25 PM

Sunday, August 30, 2009 7:49:25 PM

Post# of 257566
Re: SNY’s Otamixaban Is Unimpressive ..

"SEPIA-ACS1 study showed that otamixaban displayed clinically meaningful activity on the primary endpoint from the threshold dose of 0.070 mg/kg/h, the second tested dose, with a consistent antithrombotic effect up to the 5th highest tested dosage."

OK, am I brain dead or anal on questioning what this says?
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today